Pharmaceutical compositions comprising midazolam in a high concentration

Details for Australian Patent Application No. 2005205072 (hide)

Owner Merkus, F.

Inventors Merkus, Franciscus Wilhelmus Henricus Maria

Agent Allens Arthur Robinson

Pub. Number AU-B-2005205072

PCT Pub. Number WO2005/067893

Priority 0400804.1 14.01.04 GB

Filing date 13 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 3 March 2011

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/5517 (2006.01)

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/067893 Priority application(s): WO2005/067893

3 March 2011 Application Accepted

  Published as AU-B-2005205072

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205082-Matching numerical values

2005205067-Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders